These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19247086)

  • 41. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neoadjuvant chemoradiotherapy followed by combined thoracoscopic and laparoscopic esophagectomy in the treatment of locally advanced esophageal carcinoma].
    Zhu CC; Chen BF; Kong M; Wang CG; Wang Z; Ma DH; Ye MH; Ye ZR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):943-6. PubMed ID: 22990929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma.
    Bekkar S; Gronnier C; Messager M; Robb WB; Piessen G; Mariette C;
    Ann Thorac Surg; 2014 Jan; 97(1):303-10. PubMed ID: 24200394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis.
    Graham AJ; Shrive FM; Ghali WA; Manns BJ; Grondin SC; Finley RJ; Clifton J
    Ann Thorac Surg; 2007 Apr; 83(4):1257-64. PubMed ID: 17383322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multimodality treatment in the management of esophageal cancer: neoadjuvant chemoradiotherapy followed by transhiatal esophagectomy.
    Irwin JF; Waterfield W; Poussin-Rosillo H; Sardi A
    Md Med J; 1997 Oct; 46(9):471-76. PubMed ID: 9327648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
    Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
    Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancer.
    Yoon DH; Jang G; Kim JH; Kim YH; Kim JY; Kim HR; Jung HY; Lee GH; Song HY; Cho KJ; Ryu JS; Kim SB
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):489-96. PubMed ID: 25680595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
    Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
    Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propensity score analysis of oesophageal cancer treatment with surgery or definitive chemoradiotherapy.
    Karran A; Blake P; Chan D; Reid TD; Davies IL; Kelly M; Roberts SA; Crosby T; Lewis WG
    Br J Surg; 2014 Apr; 101(5):502-10. PubMed ID: 24615406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
    Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
    J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A review of the impact of preoperative chemoradiotherapy on outcome and postoperative complications in esophageal cancer patients.
    Wilke TJ; Bhirud AR; Lin C
    Am J Clin Oncol; 2015 Aug; 38(4):415-21. PubMed ID: 24351783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
    Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The port site recurrence after a thoracoscopic and video-assisted esophagectomy for advanced esophageal cancer.
    Yamamoto S; Kawahara K; Maekawa T; Shiraishi T; Shirakusa T
    J Thorac Oncol; 2009 Jan; 4(1):131-4. PubMed ID: 19096321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.